Document is current
Any future updates will be listed below
-
Authors
Rezk, Mamdouh R. https://orcid.org/0000-0002-4425-4390
Badr, Kamal A.
Hosny, Ahmed Abd El Hamid
AbdelMagid, Aya M. https://orcid.org/0000-0001-6175-1690
-
Funding
Funding for this research was provided by:
Atco Pharma for Pharmaceutical Industries, Egypt
Cairo University
- License Information
-
More Information
Article History
Received: 21 August 2025
Accepted: 27 October 2025
First Online: 26 November 2025
Declarations
:
: The study protocol was approved by the Independent Ethics Committee (IEC) of ARC. The Clinicaltrials.gov registration number is NCT07127094, retrospectively registered on August 15, 2025. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional committee, the Guideline for Good Clinical Practice of the International Conference on Harmonization, and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Prior to the initiation of study procedures, written informed consent was obtained from all participants. The form was explained to all subjects before signing it so that the nature, purpose, benefits and potential risks of the study were understood.
: The authors declare no competing interests.
